Matches in SemOpenAlex for { <https://semopenalex.org/work/W4290878962> ?p ?o ?g. }
Showing items 1 to 96 of
96
with 100 items per page.
- W4290878962 endingPage "13" @default.
- W4290878962 startingPage "4" @default.
- W4290878962 abstract "Human papilloma virus (HPV) is carcinogenic to humans and causes cervical cancer, as well as cancers of the vagina, vulva, penis, anus and oropharynx both in men and women. Based on this evidence the vaccines against HPV have been developed, registered and a recommended for use. These include bivalent vaccine (CERVARIX), quadrivalent vaccine (GARDASIL) and nonavalent vaccine (GARDASIL9). The effectiveness and safety of these vaccines were shown in the randomized clinical trials as well as in the real life in the countries where vaccination of girls aged 12–13 years was started in 2007–8. Vaccination prevents: a) HPV infection among vaccinated, b) cervical intraepithelial neoplasia (CIN) and c) invasive cervical cancer. World health organization (WHO) strategy to eliminate cervical cancer proposes the following targets that must be met by 2030: 90% of girls fully vaccinated by age 15; 70% women screened by 35 and again in 45 years of age. The goal of WHO is the decrease cervical cancer incidence to 4 cases per 100 000 population. In Russia the incidence of cervical cancer is on increase since early 1990 s and further rise is predicted. Mortality from cervical cancer has slightly increased in early 1990 s and since has stabilized. In 2019 the incidence (age standardized rates) of cervical cancer was 15,4 and mortality 5,6 per 100 000 population. The number of newly diagnosed cases was 17 500 and amount of dearth from cervical cancer – 6300. In this paper we assess the number of the preventable cervical cancer cases and death from this disease in women aged 15–79 years during the forthcoming years of 21 century as a result of the HPV vaccination of girls born in 2009–2018, 2019–28, 2029–2038. The prognosis is based on the incidence and mortality from cervical cancer in 2018 and predicted rates for 2032. Our assumption was that of 90% of girls under 15 years will be covered by vaccination and the effectiveness of vaccination will be 79,80% in decrease of the HPV prevalence. The estimates based on 2018 statistics suggest that among women born in 2009–2038 years – 348 850 will be diagnosed with cervical cancer and 117 862 will die from it. The timely vaccination of 90% of girls will prevent 250544 cases and 84648 deaths from cervical cancer. Based on the estimated incidence and mortality for 2032 among these cohorts of women 470 729 will be diagnosed with and 130 811will die from cervical cancer. vaccination will prevent 338 078 cases of disease and save 93 948 lives. We have shown that vaccination results in the decrease in incidence and mortality from cervical cancer and will save hundred thousands of lives. This is the strongest argument for urgent implementation of vaccination program in Russia. An additional important task is the assessment of economic impact of vaccination in comparison with the heavy burden imposed by disease and deaths from cervical cancer. The financial losses due to high incidence and mortality from cervical cancer or any other disease in addition to the costs of treatment include demographic and social factors. The latter will have largest impact on the economy and wellbeing of the country. Therefore the next step of our study will be the analyses of the cost-effectiveness of HPV vaccination in the cohort of 24 million women born in 2009–2038 based on the predicted in this paper incidence and mortality of cervical cancer and number of disease and deaths that will be prevented by vaccination." @default.
- W4290878962 created "2022-08-12" @default.
- W4290878962 creator A5001857260 @default.
- W4290878962 creator A5052847942 @default.
- W4290878962 creator A5067117085 @default.
- W4290878962 creator A5083975111 @default.
- W4290878962 date "2022-07-27" @default.
- W4290878962 modified "2023-09-26" @default.
- W4290878962 title "Prognosis of incidence and mortality from cervical cancer in Russia depending on vaccination against HPV" @default.
- W4290878962 cites W2126246455 @default.
- W4290878962 cites W2127043059 @default.
- W4290878962 cites W2159831861 @default.
- W4290878962 cites W2166678252 @default.
- W4290878962 cites W2335561727 @default.
- W4290878962 cites W2777147486 @default.
- W4290878962 cites W2955095877 @default.
- W4290878962 cites W3003227613 @default.
- W4290878962 cites W3003249044 @default.
- W4290878962 cites W3008411320 @default.
- W4290878962 cites W3081575934 @default.
- W4290878962 cites W3090300247 @default.
- W4290878962 cites W3095086510 @default.
- W4290878962 cites W3155324950 @default.
- W4290878962 cites W3209481766 @default.
- W4290878962 doi "https://doi.org/10.21045/2782-1676-2022-2-2-4-13" @default.
- W4290878962 hasPublicationYear "2022" @default.
- W4290878962 type Work @default.
- W4290878962 citedByCount "0" @default.
- W4290878962 crossrefType "journal-article" @default.
- W4290878962 hasAuthorship W4290878962A5001857260 @default.
- W4290878962 hasAuthorship W4290878962A5052847942 @default.
- W4290878962 hasAuthorship W4290878962A5067117085 @default.
- W4290878962 hasAuthorship W4290878962A5083975111 @default.
- W4290878962 hasBestOaLocation W42908789621 @default.
- W4290878962 hasConcept C120665830 @default.
- W4290878962 hasConcept C121332964 @default.
- W4290878962 hasConcept C121608353 @default.
- W4290878962 hasConcept C126322002 @default.
- W4290878962 hasConcept C131872663 @default.
- W4290878962 hasConcept C143998085 @default.
- W4290878962 hasConcept C179755657 @default.
- W4290878962 hasConcept C203014093 @default.
- W4290878962 hasConcept C22070199 @default.
- W4290878962 hasConcept C2777265743 @default.
- W4290878962 hasConcept C2777343196 @default.
- W4290878962 hasConcept C2778220009 @default.
- W4290878962 hasConcept C2778308922 @default.
- W4290878962 hasConcept C2778580637 @default.
- W4290878962 hasConcept C2779840525 @default.
- W4290878962 hasConcept C2780009117 @default.
- W4290878962 hasConcept C2908647359 @default.
- W4290878962 hasConcept C29456083 @default.
- W4290878962 hasConcept C61511704 @default.
- W4290878962 hasConcept C71924100 @default.
- W4290878962 hasConcept C99454951 @default.
- W4290878962 hasConceptScore W4290878962C120665830 @default.
- W4290878962 hasConceptScore W4290878962C121332964 @default.
- W4290878962 hasConceptScore W4290878962C121608353 @default.
- W4290878962 hasConceptScore W4290878962C126322002 @default.
- W4290878962 hasConceptScore W4290878962C131872663 @default.
- W4290878962 hasConceptScore W4290878962C143998085 @default.
- W4290878962 hasConceptScore W4290878962C179755657 @default.
- W4290878962 hasConceptScore W4290878962C203014093 @default.
- W4290878962 hasConceptScore W4290878962C22070199 @default.
- W4290878962 hasConceptScore W4290878962C2777265743 @default.
- W4290878962 hasConceptScore W4290878962C2777343196 @default.
- W4290878962 hasConceptScore W4290878962C2778220009 @default.
- W4290878962 hasConceptScore W4290878962C2778308922 @default.
- W4290878962 hasConceptScore W4290878962C2778580637 @default.
- W4290878962 hasConceptScore W4290878962C2779840525 @default.
- W4290878962 hasConceptScore W4290878962C2780009117 @default.
- W4290878962 hasConceptScore W4290878962C2908647359 @default.
- W4290878962 hasConceptScore W4290878962C29456083 @default.
- W4290878962 hasConceptScore W4290878962C61511704 @default.
- W4290878962 hasConceptScore W4290878962C71924100 @default.
- W4290878962 hasConceptScore W4290878962C99454951 @default.
- W4290878962 hasIssue "2" @default.
- W4290878962 hasLocation W42908789621 @default.
- W4290878962 hasOpenAccess W4290878962 @default.
- W4290878962 hasPrimaryLocation W42908789621 @default.
- W4290878962 hasRelatedWork W153838260 @default.
- W4290878962 hasRelatedWork W1568413287 @default.
- W4290878962 hasRelatedWork W1974553392 @default.
- W4290878962 hasRelatedWork W1976965171 @default.
- W4290878962 hasRelatedWork W1986099429 @default.
- W4290878962 hasRelatedWork W2023383225 @default.
- W4290878962 hasRelatedWork W2254324609 @default.
- W4290878962 hasRelatedWork W2924405505 @default.
- W4290878962 hasRelatedWork W4290878962 @default.
- W4290878962 hasRelatedWork W2739024588 @default.
- W4290878962 hasVolume "2" @default.
- W4290878962 isParatext "false" @default.
- W4290878962 isRetracted "false" @default.
- W4290878962 workType "article" @default.